THE COMPANY HAS SUCCESSFULLY COMPLETED T...

2015/05/15
The board of directors of Luye Pharma Group Ltd. (the "Company") is pleased to announce that the company has completed the following three clinical studies involving a total of 172 patients in the United States (the "U.S.") for an investigational drug product of risperidone ("LY03004"), formulated a...

Sort
Name
About Us Marketed Products R&D Media Center Investor relations Join us Contact Us